As all phys icians know, life is extre mely fragile. Th e difference between life and deat h ca n be determi ned not only by the ski ll of a surgeo n, or lack of it, and the acc uracy of diagnosis, but also by bei ng at the wro ng place at the wrong tim e to be struc k dow n by an acc ide nt or disaster. Those who lived in earlier tim es did not have the benefit of antibiotics and the surgica l technique s of today and met death fro m infecti on s that are now treatable . We expec t that in the futur e, the thi ngs physicians do now will be unnecessary becau se of new and wond erful meth od s to pre vent and cure dis ease.
I have per sonally found preparation for this issue of ENT JOURNAL especially difficult , in writing the obituary of my friend Jean-Bern ard Cau sse. In Dec emb er 2000, one year before Jean-Bernard ' s death , he , Dr. Ch ristian Deguine, and I, along with our wives, spent a wonder ful evening in Paris to celebrate ove r dinner the publ ication of our Atlas ojOtoscopy. Jean-Bernard was vibra nt and full ofl ife. He had wri tte n the compliment ary pre face to the Atlas, which Dr. Deguin e and I had authored. Each of us inscribed the others' cop ies. In April 200 1, we learned that Jean-Bern ard had am yloid osis and in the next months agonize d as his condition grew worse. He was treated by excellent specialists, with regul ar con sult ation from the world' s expert in this uncommon and generally fat al disease.
A new drug manufactured in Jap an, interleukin 6 (IL-6), offered promise of contro lling the disease. Although trials on IL-6 were bein g conducted in Europe, the officials in cont rol denied this life-saving medication to our friend. Eu ropean gove rnment bureauc rats, acting in much the sa me way as the FD A operates in the US A (the dru g IL-6 is not ava ilable at all in the Un ited States), acted to prevent Jean-Bern ard from receivin g this dru g. We do not kn ow whether IL-6 would have been of any benefit, but it see ms difficult to believe that governments have not go ne way too far in dict ating what medical treatment can be used and to whom it will be made ava ilable. Th e need for government to be able to make exceptions to their directi ves, for humanitarian reaso ns, is emphasized in the ca se of Jean-Bernard Causse . 
